Search Results
Baxter Reports Third-Quarter 2018 Results and Updates Financial Outlook for Full-Year 2018
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported results for the third quarter of 2018 and updated its full-year 2018 financial outlook.
Baxter Receives CE Mark for PrisMax, the Next-Generation System for Continuous Renal Replacement and Organ Support Therapies
Baxter International Inc. (NYSE:BAX), a global leader in acute care, announced today the company received CE mark of both its PrisMax system and its TherMax blood warmer. PrisMax is the company’s next-generation technology for continuous renal replacement and organ support therapies.
Baxter Highlights Clinical Data at ASN: Kidney Week Showing How New Technologies are Advancing Dialysis Care Across Modalities
Baxter International Inc. (NYSE:BAX), a global innovator in renal care, highlighted findings from HDx (expanded hemodialysis) and peritoneal dialysis (PD) studies presented at the American Society of Nephrology (ASN): Kidney Week, Oct. 23-28, showing how novel renal care technologies are positively impacting patient care and clinic efficiency.
Baxter Announces U.S. Regulatory Filing for PrisMax Acute Care System and Presentation of 15 Abstracts to Start ASN: Kidney Week 2018
Baxter International Inc. (NYSE:BAX), a leading global medical products company, announced it has submitted the PrisMax system for 510(k) clearance to the U.S. Food and Drug Administration (FDA).
Baxter to Showcase Critical Care Innovation at the 2018 European Society of Intensive Care Medicine Congress
Baxter International Inc. (NYSE:BAX), a leading global medical products company, will highlight its latest innovations in critical care at the 2018 European Society of Intensive Care Medicine (ESICM) congress in Paris from Oct. 20-24.
Baxter and ASPEN Launch 'Smart PN' Tools to Reinforce Appropriate Use of Parenteral Nutrition
Today the American Society for Parenteral and Enteral Nutrition (ASPEN), an organization which drives the science and practice of clinical nutrition, and Baxter International Inc. (NYSE: BAX), a global leader in clinical nutrition, launched an educational video series on the appropriate use of parenteral nutrition (PN), as part of the organizations’ “SmartPN” collaboration to help reduce clinical malnutrition that was announced last year.
New Jersey Community Hospital First to See the Benefits of the New SPECTRUM IQ Infusion System
Baxter’s latest innovation in medication delivery showcases our commitment to advancing healthcare for patients and providers
Baxter to Present at the 27th Annual Credit Suisse Healthcare Conference
Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the 27th Annual Credit Suisse Healthcare Conference in Scottsdale, Ariz. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present on Wednesday, November 14, 2018 at 8:00 a.m. Mountain Time.
Baxter and Mayo Clinic Announce Collaboration to Establish Renal Care Center of Excellence in the U.S.
Baxter International Inc. (NYSE:BAX), a global innovator in renal care, and Mayo Clinic today announced a new collaboration to develop a renal care center of excellence in the U.S. The center will serve patients across the continuum of renal care — from chronic kidney disease (CKD) management through transplant — and drive better patient outcomes.